Financials

  • Market Capitalization 1.38 M
  • Employee 838
  • Founded 2007
  • CEO N/A
  • Website www.iovance.com
  • Headquarter Delaware, United States
  • FIGI BBG000FTLBV7
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.5
Price to sales ratio
0
Dividends per share
Dividend yield %

Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

ニュース